Skip to main content
Clinical Trials/CTRI/2025/07/090377
CTRI/2025/07/090377
Not yet recruiting
Not Applicable

Impact of combining high-dose high-intensity upper limb training with motor learning techniques on improving hand functions and overall quality of life in individuals with chronic stroke.

Not provided2 sites in 1 country70 target enrollmentStarted: July 17, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
70
Locations
2
Primary Endpoint
Fugyl-Meyer Assessment- Upper Extremity (FMA-UE)

Overview

Brief Summary

**Title:**Impact of combining high-dose, high-intensity upper limb training with motor learning techniques on improving hand functions and overall quality of life in individuals with chronic stroke.

**Background:**Stroke incidence in India is high (1.44–1.66 million new cases annually), with 86.5 deaths per 100,000 yearly. Over 90% of survivors experience upper limb motor dysfunction, leading to long-term disability—66% remain dependent on daily activities five years post-stroke. Current rehabilitation focuses on lower limbs, while upper limb recovery plateaus after three months due to insufficient therapy intensity and limited integration of motor learning strategies.

Objectives:

  1. Assess the impact of high-dose, high-intensity upper limb training combined with motor learning techniques on Fugl-Meyer Assessment-Upper Extremity (FMA-UE), Action Research Arm Test (ARAT) and Jebsen-Taylor Hand Function Test (JTHFT)

  2. Reduce upper limb impairments (Modified Ashworth Scale, range of motion).

  3. Enhance quality of life (Stroke-Specific Quality of Life Scale, SS-QOL).

  4. Investigate associations between age, sex, stroke laterality (dominant/non-dominant), and recovery.

  5. Evaluate maintenance of benefits at 6-week follow-up.

Methods:

  • Design: Randomized controlled trial (70 participants, 35 per group).
  • Population: Chronic stroke patients (>3 months post-stroke) with upper limb impairment.
  • Intervention Group: 4-week protocol: 2 hours/day, 5 days/week (40 total hours) of high dose, high-intensity upper limb training + motor learning strategies (task-specific practice, feedback). Adjunct: Aerobic exercise (1 hour/day, 2 days/week). FITT-based: Tailored to ACSM guidelines for stroke.
  • Control Group: Standard rehabilitation (passive stretches, joint mobilizations).
  • Outcome Measures: Baseline, post-intervention (4 weeks), and follow-up (6 weeks) assessments of FMA-UE, ARAT, JTHFT, and SS-QOL

**Significance:**This trial addresses the critical gap in upper limb rehabilitation by combining high-dose training (time/repetitions) with motor learning techniques to promote neuroplasticity and functional recovery in chronic stroke. It challenges the post-3-month recovery plateau and aims to establish a scalable, evidence-based protocol for improving hand function, independence, and quality of life. Results may form clinical guidelines for aggressive, integrated upper limb rehabilitation in resource-limited settings.

**Innovation:**First study in India to integrate high-dose training (40 hours) with motor learning strategies in chronic stroke, targeting long-term functional gains and quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • a) A first-ever unilateral stroke (ischaemic or haemorrhagic) as defined by WHO, at least 6-months previously. b) Moderate upper limb impairment as defined by Fugyl-Meyer Assessment.
  • Upper Extremity (Woodbury et al., 2007) score between 19-46 (to avoid ceiling and floor effects) c) Trace of muscle contraction in wrist extensor. Max 4 on the (Medical RCS) for shoulder elevation and elbow flexion/extension. d) Ability to follow 2 step commands.

Exclusion Criteria

  • a) Other neurological diagnoses.
  • b) Serious cognitive impairment.
  • c) Increased muscle tone in wrist/finger extensors.
  • d) Orthopaedic Impairment or Visual disorder limiting the treatment.
  • e) Unable to give informed consent form.

Outcomes

Primary Outcomes

Fugyl-Meyer Assessment- Upper Extremity (FMA-UE)

Time Frame: Data will be collected at baseline (T0), post-intervention (T1) at 4 weeks, and follow-up time points after 6 weeks (T2) in both groups.

Secondary Outcomes

  • Action Research Arm Test (ARAT)(Data will be collected at baseline (T0), post-intervention (T1) at 4 weeks, and follow-up time points after 6 weeks (T2) in both groups.)
  • Jebsen-Taylor Hand Function Test (JTHFT)(Data will be collected at baseline (T0), post-intervention (T1) at 4 weeks, and follow-up time points after 6 weeks (T2) in both groups)
  • Stroke-Specific Quality of Life Scale (SS-QOL)(Data will be collected at baseline (T0), post-intervention (T1) at 4 weeks, and follow-up time points after 6 weeks (T2) in both groups.)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Dr Nirav P Vaghela

K. M. Patel Institute of Physiotherapy Bhaikaka University

Study Sites (2)

Loading locations...

Similar Trials